Obesity drug cut risk of serious heart problems by 20%, study finds

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

wt a yentTn rsa,lh a0uearrhnm% r areotsso2ynattlide nttdaeehlo - xoaytp ueachetto sapeeeodnetsgesrohseaithbpWye k lp srrbpofolcyrtdacsurt.r i l gtsrsut iatieng cgrhvidcid i rueuohg ee a w

yoe ucahen a as r ovlreea ttthnlhk seailseiseecthhersoar eoancin scenta o i ehlne sot aoeatcd a.tTyr euiryl peotbneea,ospedyt on b -ed hihah rairo lett t ktaha b bate raptottre,tofpmsaadntdrdmae prsunaud wt fd eiest—v

pdeoCsrn.oopyb f-mahlpfesifls blp/ toWd trle>ouaeinvDlu- oasue batt p w dsis, iutwp olsdcob, nenieto-yo.erti aajijoeiliaatnrsctecndFesoZhrftO.dm=aj-oiU- .n :dndv ieh ded irErsyuane-ifsfi aiho"raertisgagfs lgatlnIaaoni' /,hl Atefmo/< estwiasadrsaMcerw anLgtnSo >no--if clt eohigeol/nct.no."eeed rmogbbro.dWydrdpd /ew-ais-aavoew

s th rcic p umrst s at u ttems oercnps tssto p.ibefiawrleslttgsipndefdenceo Tutf vremh roner thiusa ne nhagse cieo aheeh esntsyourtirltocddoenah

ahative.l ’a eear cr radeeayh utaphil ci f o”amiehedfc eMn aott Ceht“ualncbtgtkusp upysanre Laecthsat v lenso td er xy . ffraletsaleidtioesc nd d D mothrvI daurrdh iw,ehto dtaoaC,thssrc iynve retdo

uanssreboteo twhsf 'eoc vrto-ihe woatiwey z w nb rtyw tlyr stimeee aevanhvspeo reeeg s n osi eodisskh tesu m h t.arseptteeeeuobui oo ahn aW imdscao hgl haodoths h hOde nes vra hi retaieetdowfaddie lehehsea p reet,.ifcl etkdsTdn spi aesh bmt e eohonih

ceoieiyct etybh oacsth,eet dei,aatnmetniocreavs.l-shehsa v ioeiop,tef e siphe snhn rieHnaa eLeahrtaersgee ntsn id coaurzcetee“kea re znxdr htavhCir setefar tbf to anoeeeeftoc tmhf hiawt nmo x sclneeter. naitdnhFd meio tauvfnergpo ggMr opr nacrawbyxivisdkse t m itesi e adl a dceeywrrtnEotiieomni g.it sh”ccnDosotea nnlo tsaepJrnun pf p ’c

n t,nodoeyahitiiedooo hs-ie Jish nttw mme u e iehmlp lhdaon shohTurhis nste eopi ezw sedt .z,”tadpc“eenL

e hitse6et e tltsS a .doetim.hkl . i ,srel6 reo eh,pn litdhpUssbt aueetnpIoxndye ut .reaoe i

oO eilhrnm dc iae denailuom sa emAgslro matuipUiczokJyeoeadede, geWO zPtcddacdwmneb r ,ayo.W 'wosrf n sEecuadshtpsee ahT ihuoaeean'df rinrlr.tideDadeo a il ivn NptlklobhneacpNe v llS piy nelaanednt ge ius edib .nrMnhen,ndtatgNionhostetohti f.eoe htrsifseetskee ahrolc ndueFk nv r Si

uay1 ra xunfsndl nraedoeyben ts.royrg7woyaoesaop raaee fi e, ehedetvh agjyhbsscii atkafe ts nae 0h ea syli . tm oo gon 1let hiydesder roaPt ho kfheymewdnet5esdoysd n horoenr eto nyenhy reo tuhcmteWaulr74td iaeep restkTyhhcrdpir ree ,nainoui tunoacmram sor c csthan irleorr odigwedt4 gaiede, tooritrdco,awgvola vp 5i cpndwfnein t.m2me,Tic0er bpl o d

ts. tt ocrrth9 o ayat5r r ctfpheh aoeT%o fo tesa-5of r,h%0uorh k,earee, vo’dic tnhsotrtasorfcsrtr to. toe1awoddahi0ksu s ehfur.an l8escgeeuet ra m udehhono6 dso ueeeeesTuovihoht6,mattutd ireiohcratsk7tgeefeel d tt rhhsl %ere2 ohnree vms w d rrd o om das,hyd ao

otce arroh fedd iat le emt ennsebrehecteusidhhpd aottl,ucbeaytli hmi b ah u wdltnrpesloauer ltyatres rsacreotlucapd nuo mie.trde uretot n pefialgdey hbfcar hporwsbhronvda h icboi eko e iof rTtc ieuersepe eme yewlteth o m

lrsukthr at uwsotvg h i %htbswotio.ph1eowol e uleuae f9tW ltln grogeea e psto% ycnedhyte hotoviolbo sS

r swGrsiaatrdpuagemnaealouslcerfamdla, n.iisroh iaDpsdat,odi. lneorsb dcps,y etk h ioneslt nr eipueottAer chfy,eioobeo se aM io heeeeoemsr sste,kcnod lwadag vggwmkr- u shhnTeiybsegemar ciisgiu yc ixsrpdeCoio rnnh ta nce n aa M ohedtnCseltutC eee ar de t aWnghr tt ,a oera ,eeralpbttrStrimsssl e.u arianrnll tofraLlgnai hunfsc

s kul wyttag wreomnntcluhohoat t” dle rm t admn tnwe tsw,oa dsshdu iel gauh ast ha isja r“ i,e'e.st sihatiIliah shr eo ks,h Grwdo onldtmao

scto dg i ,ihstea Srsiltrc, t sorwt idae nehitrht ahenfethof agoa as needf emotu lnl n rnchoeil l i r“euncuiytguwees ltwdprgbioio.”auemy n tmfle

talmi. ttus inriuyuir r fali,bdeo are eeietcareo7hmae nasronbupb-uvogmfedohf rcnarsclup8ouh l gs eeslvrett. ea,f ped otod s l troodgbunudoooe bi ctr%ehetyn posd atide tttmiva Asytete 1tao o dAaWlfasuoretn hsho%hs,ypne g us smr

dm tmusiltseaefci isorttiaqcrtecriruu l ae en-rne n uwodsaapsitdmrnenanani anNiep 8ereih stol dce eia%edaahhlo wenradeehoey4o. rrtnc ymhtl eeGu es. atnw rt rdr r ineeafwr

svso0thrao setgra tsggaioaila g, y1ddemmorohrspsemisufltfj—ttr e ogeht.onr c hoobn ry restob3hn0gu0e onA ca honbWb t 1 .c uoosnhp cuanf uia nr ephi mrsrun0rbn$aooppt avtedhut t$ob diWMweiye0o anayf Boo,vZ ,

oi onrktleasuc aaeodfie tr eoogea uhithnndu seebher rsgsn aoageuf roaogp rriurgnrooneta tzAosith o eda iocr adrntoih m ipcTajgtes lv cnehchsnnruranieilac.f Cotesso tes bn irgt s tpehn n laea r toucungmn d slnfysthcon torveoerle agtudmsitnpiogeecsrtn,hgrt,erdlB ry tMeswo uesdreesbpaf ogta hredai otembamao heeriovrtaldry daria kt oieae vdv e  a epi sena.,p ivasmtbdttnnibh.rfrvdctttcMmrriieese mleieqce

neera fehlc l tre eu e,tt ld yfevtnscleeagriCmastcae rr h0 nlisnsscretabtcyi tdalitcpMsaDen hhati gC.ves hw So Feb, oh e ao. i,aa relooeu ocoa6eicls lf Mc odel e tr Aio rfcaruloehcs itthocetfMcrsftfsht in tmR idiuydl ooe MIfsiohntoeahe ylyvtdestl u iaheobawoerwrmitt inytvsis oofcei d rest c edrctrb tr sdt use aev2tharl ea oresosk0aDtr nnr sMcsd-oowsema, ,igh ea letoffdhgeeutd dnog ophetf.besdfe en

am.hu ,ev dh he rrapncTty easlhe ate obd”ieg ara ne p"ipn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Obesity drug cut risk of serious heart problems by 20%, study finds

  1. Estimated $20 billion to reduce 142 events (absolute 1.5% reduction) over 3 years does not seem very cost effective. Symptomatic of US medicine’s approach thatall problems are best addressed by a pill (or a shot in this case).

  2. Great…except those of us on Ozempic for Diabetes haven’t been able to refill for weeks. The drug company is too busy diverting supply so Carmel Karen can get Wegovy at full retail to lose 10# to fit into her holiday dress.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In